GlaxoSmithKline plc (GSK) is a global healthcare group engaged in the creation, discovery, development, manufacture and marketing of pharmaceutical and consumer health-related products. It has and operations in some 114 countries, with products sold in over 140 countries. The Company... more

Invitrogen Corporation (Invitrogen) is a developer, manufacturer and marketer of research tools in reagent, kit and high-throughput applications forms to customers engaged in life sciences research, drug discovery, diagnostics and the commercial manufacture of biological products. The... more

Anadys Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to improving patient care by developing novel medicines in the areas of hepatitis C and oncology. We are developing ANA598, a small-molecule, non-nucleoside inhibitor of the HCV polymerase (NS5B) for the treatment of... more

Celgene Corporation is an integrated biopharmaceutical company. The Company is primarily engaged in the discovery, development and commercialization of therapies designed to treat cancer and immune-inflammatory-related diseases. The Company’s lead product is REVLIMID (lenalidomide) and... more

Headquartered in Basel, Switzerland, Roche is one of the world's leading research-focused healthcare groups in the fields of pharmaceuticals and diagnostics. As the world's biggest biotech company and an innovator of products and services for the early detection, prevention, diagnosis and... more

CuraGen Corporation (CuraGen) is a biopharmaceutical development company engaged in developing therapeutics for the treatment of cancer. The Company is focused on advancing its cancer treatments, belinostat and CR011-vcMMAE, through clinical development and toward commercialization. In... more

Schering-Plough Corporation (Schering-Plough) is a global science-based healthcare company with prescription, consumer and animal health products. Through internal research and collaborations with business partners, Schering-Plough discovers, develops, manufactures and markets advanced... more

Tranzyme Pharma is developing a number of mechanism-based therapeutics for the treatment of gastrointestinal (GI) and metabolic diseases. GI and metabolic diseases are characterized by large, underserved markets with few or poorly performing drugs for most indications. The Company is... more

Exelixis, Inc. is a biotechnology company engaged in the development of differentiated pharmaceutical products for the treatment of cancer and other serious diseases. Exelixis has a pipeline of compounds in various stages of development that will potentially treat cancer, renal disease... more

Abbott Laboratories is engaged in the discovery, development, manufacture and sale of a diversified line of healthcare products. It has four segments. The Pharmaceutical Products segment’s products include adult and pediatric pharmaceuticals. The Diagnostic Products segment’s products... more

Bristol-Myers Squibb Company (BMS) is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceuticals and other healthcare-related products. During the year ended December 31, 2007, the Company had three segments: Pharmaceuticals,... more

ExonHit Therapeutics is a worldleading company in developing novel pharmaceuticals and diagnostics from its unique understanding of alternative RNA splicing, the process by which a single gene can lead to several proteins. The company's proprietary gene profiling technology DATASÔ, allows... more

Myriad Genetics, Inc. is a healthcare company focused on the development and marketing of molecular diagnostic and therapeutic products. The Company’s molecular diagnostic business focuses on the analysis of genes and their alterations to assess an individual’s risk for developing disease... more

Galapagos is a drug discovery company with two operating divisions: drug discovery and BioFocus DPI, Galapagos' service division. Galapagos' drug discovery division aims to develop novel, disease-modifying drugs in selected bone and joint disease areas for which there is a need for safe... more

Celera Corporation (Celera) is a healthcare business delivering personalized disease management through a combination of products and services. The Company operates in three segments: a clinical laboratory testing service business (Lab Services), a products business (Products), and a... more

Human Genome Sciences (HGS) is a commercially focused biopharmaceutical company. The Company has three products in late-stage clinical development: Albuferon for chronic hepatitis C, LymphoStat-B for systemic lupus erythematosus and ABthraxtm for inhalation anthrax. All three of these... more

Array BioPharma Inc. (Array) is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs. The Company’s drug development pipeline includes clinical candidates that are designed to treat patients afflicted with cancer,... more

GenVec, Inc. (GenVec) is a clinical stage biopharmaceutical company developing gene-based therapeutic drugs and vaccines. Its lead product candidate, TNFerade biologic (TNFerade), is being developed for use in the treatment of cancer. As of December 31, 2007, TNFerade was the subject of a... more

Incyte Corporation (Incyte) is a drug discovery and development company focused on developing small molecule drugs to treat serious unmet medical needs. The Company has a pipeline with programs in oncology, inflammation, diabetes and human immunodeficiency virus (HIV). Its pipeline... more

GPC Biotech AG is a biopharmaceutical company, which is engaged in the discovery, development and commercialization of anticancer drugs. Its lead product candidate is satraplatin, a platinum-based compound intended for use as a chemotherapy treatment. Unlike other platinum-based drugs,... more

BioVex is a biotechnology company focused on the development of novel biologics for the treatment of cancer and infectious disease. Our lead product for the treatment of cancer is OncoVEXGM-CSF. OncoVEXGM-CSF is in Phase II clinical development and is currently being tested in clinical... more

Millennium Pharmaceuticals, Inc., a leading biopharmaceutical company based in Cambridge, Mass., markets VELCADE, a novel cancer product, co- promotes INTEGRILIN® (eptifibatide) Injection, a market-leading cardiovascular product, and has a robust clinical development pipeline of product... more

Cyclacel is a biopharmaceutical company that designs and develops small molecule drugs that act on key cell cycle regulators to stop uncontrolled cell division in cancer and other diseases involving abnormal cell proliferation. The Company's discovery engines integrate cell cycle biology... more

InSite Vision Incorporated is an ophthalmic product development company focused on ophthalmic pharmaceutical products based on its DuraSite drug delivery technology. Its DuraSite sustained delivery technology is a synthetic polymer-based formulation designed to extend the residence time... more

Acadia Pharmaceuticals Inc. (Acadia Pharmaceuticals) is a biopharmaceutical company focused on the discovery, development, and commercialization of small molecule drugs for the treatment of central nervous system disorders. The Company has six programs in clinical development and several... more

Applied Biosystems Inc. (Applied Biosystems) is engaged in the development and marketing of instrument-based systems, consumables, software, and services for academic research, the life science industry and commercial markets. It commercializes technology solutions for deoxyribonucleic... more

Predix is a privately held, clinical stage drug development company that uses a proprietary discovery and lead optimization system to develop drugs for G-protein coupled receptor (GPCR) and ion channel targets. Over the past two and a half years, the company has discovered several novel... more

Avalon Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of first-in-class cancer therapeutics. Its lead product candidate, AVN944, an inosine monophosphate dehydrogenase (IMPDH) inhibitor, is in Phase II clinical development.... more

Rigel Pharmaceuticals, Inc. (Rigel) is a clinical-stage drug development company that discovers and develops small molecule drugs for the treatment of inflammatory/autoimmune diseases, cancer and viral diseases. The Company's research focuses on intracellular signalling pathways and... more

Syrrx invests in its people, science, and technology to create products of value and social worth. The company dedicates and directs its capabilities and resources to discovering drugs that will ultimately benefit mankind. Syrrx has developed innovative science and technology that is... more

Genencor is a diversified biotechnology company that develops and delivers innovative products and services into the health care, agri-processing, industrial and consumer markets. Using an integrated set of technology platforms, Genencor's products deliver innovative and sustainable... more

diaDexus makes a difference by developing innovative products to detect cancer and cardiovascular disease.

Morphotek(R), Inc., a subsidiary of Eisai Co., Ltd., is a biopharmaceutical company specializing in the development of protein and antibody products through the use of a novel and proprietary gene evolution technology. The technology has been successfully applied to a broad variety of... more

Sequenom, Inc. is a genetics and molecular diagnostic company providing genetic analysis products and services and developing diagnostic tests initially targeted at non-invasive prenatal genetic disorders. The Company's genetic analysis business provides applications that translate... more

Genome Therapeutics is a biopharmaceutical company focused on the discovery and development of pharmaceutical and diagnostics products. The Company's first product candidate, Ramoplanin, is in a Phase III clinical trial for the prevention of bloodstream infections caused by... more

Gene Logic, headquartered in Gaithersburg, Md., has developed proprietary genomics databases and services to enable customers worldwide to discover and prioritize drug targets, identify biomarkers, predict toxicity, understand mechanisms of toxicity, and obtain insights into the efficacy... more

Cytochroma Inc. is a development stage specialty pharmaceutical company focused on the treatment and prevention of disorders related to Vitamin D insufficiency. The Company has a portfolio of therapeutics with lower development risk for the indications of Vitamin D insufficiency and for... more

We are a biopharmaceutical company focused on the discovery, development and commercialization of novel small-molecule product candidates directed toward clinically validated targets in significant therapeutic markets. We designed our product candidates to have improved efficacy, safety... more

A: EraGen was founded in 1994 as Sulfonics, Inc., a California corporation. It changed its name to EraGen Biosciences and was reincorporated in Delaware in 1999. In 2002 the company consolidated its operations from Florida to new facilities in Madison, Wisconsin. Q: How large is EraGen?... more

Tularik is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease.... more

Oxagen is focused on becoming a significant biopharmaceutical company, developing a pipeline of novel drugs to treat inflammatory diseases. The Company has created a portfolio of valuable drug targets centered on the highly attractive class of receptors, GPCRs. Through its heritage in... more

Affymetrix, Inc. is engaged in the development, manufacture, sale and service of consumables and systems for genetic analysis in the life sciences and clinical healthcare markets. The markets for the Company’s products include all aspects of molecular biology research in the life... more

Lexicon Pharmaceuticals, Inc. (Lexicon) is a biopharmaceutical company focused on discovering and developing treatments for human disease. The Company uses its proprietary gene knockout technology to identify and develop new drugs. In its Genome5000 program, Lexicon is utilizing its... more

Isis Pharmaceuticals, Inc. (Isis) is a biopharmaceutical company engaged in antisense technology, exploiting a drug discovery platform to create a pipeline of drugs. In addition to its antisense programs, the Company maintains technology leadership beyond its core areas of focus through... more

SeraCare Life Sciences, Inc. is a global leader in the development and commercialization of biological products and services that enhance and protect the clinical research, diagnosis, and manufacture of drugs and vaccines for infectious diseases. SeraCare is dedicated to providing high... more

Genaissance is focused on integrating the use of human gene variation into the development of a new generation of DNA-based diagnostic and therapeutic products. The Company markets its HAPÔ Technology, clinical development skills and services to the pharmaceutical, biotechnology and... more

About Inpharmatica: (http://www.inpharmatica.com) Founded in 1998, Inpharmatica Ltd is a selective drug discovery company using predictive technologies to improve speed and productivity. Focusing on highly druggable targets, its unique proprietary platform, PharmaCarta (TM), is an... more

Karo Bio AB is a Swedish pharmaceutical company, engaged in the development of precision drugs to treat major diseases in the field of nuclear receptors. The Company primarily focuses its research and development (R and D) activities on three areas, including lipoproteins, diabetes and... more

Quark Pharmaceuticals, Inc. is a development-stage pharmaceutical company focused on discovering and developing novel therapeutics based on its proprietary gene discovery science and technology, with an initial focus on drug candidates that work through the natural mechanism in the cell... more

VASTox is a chemical genomics company that discovers and develops proprietary new drugs and provides a range of screening and chemistry services to the life sciences industry. VASTox was formed in January 2003 and is listed on the AIM segment of the London Stock Exchange (Ticker: VOX).